Compared side by side
Thymalin vs vilon: how they differ
The short answer
Vilon is one of thymalin’s active parts: thymalin is a peptide extract of calf thymus, and vilon is the two-amino-acid peptide Lys-Glu that the same Russian group makes on its own. In lymphocytes from old people grown in the lab vilon loosened tightly packed chromatin, and in human immune cells thymalin and its two dipeptides lowered the inflammatory signals IL-1β, IL-6 and TNF-α. Their human studies are small and almost all by their developers, none described as randomized, and both are run daily in short courses of about 5–10 days.
Side by side
| Compared | Thymalin | Vilon |
|---|---|---|
| Category | Healing & recovery | Healing & recovery |
| Also known as | Timalin, Thymaline, Thymus peptide complex | Lys-Glu, KE dipeptide, Lysylglutamic acid |
| What it is | A peptide extract of calf thymus from the Russian bioregulator program behind Epitalon, used as an immune drug. | A two-amino-acid peptide (Lys-Glu) from the Russian bioregulator program and one of the active parts of the thymus extract Thymalin. |
| How it works | A peptide extract of calf thymus, one of the first two products of Vladimir Khavinson's St. Petersburg bioregulator program, used as an immune drug. Its active parts include two dipeptides the same group later made on their own: Lys-Glu (Vilon) and Glu-Trp (Thymogen). In human blood stem cells in the lab it pushed immature cells toward mature T cells, and in human immune cells it and its two dipeptides lowered the inflammatory signals IL-1β, IL-6 and TNF-α. In people, a study of 266 older adults followed for 6 to 8 years reported fewer deaths with it than in a control group, and in severe COVID-19 its developers report lower hospital mortality when it was added to basic therapy; neither study is described as randomized or blinded, and almost all of the work is by its developers. It is a different substance from thymulin and from thymosin alpha-1. | A dipeptide, Lys-Glu (KE), from Vladimir Khavinson's St. Petersburg bioregulator program and one of the active parts of the thymus extract Thymalin; Russian papers call it thymomimetic, a peptide that acts like the thymus on the immune system. In lymphocytes from old people grown in the lab it loosened tightly packed chromatin, which its developers read as switching silenced genes back on, and in old male rats it raised sexual function and lowered prolactin. In people with type 1 diabetes, small Russian studies with no placebo group report calmer blood clotting and, in most, less insulin needed. Almost all of the research is by its developers. |
| Commonly reported | Little to feel during a course; injection-site soreness is the usual complaint. | Little to feel during a short course; it is often run beside Epitalon. |
| Studied range | No study indexed on PubMed states or tests a dose of Thymalin: the amounts people run are their own protocol, not a reference. | No controlled study has set a dose of Vilon: the amounts people run are their own protocol, not a reference. |
| How often | Daily | Daily |
| Half-life | Unknown (never measured) | Unknown (never measured) |
| Route | IM injection, SubQ injection | SubQ injection, Oral capsules |
| Typical run | Run in short courses rather than continuously, like the other bioregulators: commonly 5–10 days, repeated months later. In the long Russian follow-up study, courses were given during the first two to three years only. No study has tested a course length. | Run in short courses rather than continuously, like the other bioregulators: community courses run about 5–10 days, a few times a year. No study has tested a course length. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Injection-site pain or redness, firmness at the injection site | Injection-site discomfort, mild stomach upset (capsules) |
- Category
- ThymalinHealing & recovery
- VilonHealing & recovery
- Also known as
- ThymalinTimalin, Thymaline, Thymus peptide complex
- VilonLys-Glu, KE dipeptide, Lysylglutamic acid
- What it is
- ThymalinA peptide extract of calf thymus from the Russian bioregulator program behind Epitalon, used as an immune drug.
- VilonA two-amino-acid peptide (Lys-Glu) from the Russian bioregulator program and one of the active parts of the thymus extract Thymalin.
- How it works
- ThymalinA peptide extract of calf thymus, one of the first two products of Vladimir Khavinson's St. Petersburg bioregulator program, used as an immune drug. Its active parts include two dipeptides the same group later made on their own: Lys-Glu (Vilon) and Glu-Trp (Thymogen). In human blood stem cells in the lab it pushed immature cells toward mature T cells, and in human immune cells it and its two dipeptides lowered the inflammatory signals IL-1β, IL-6 and TNF-α. In people, a study of 266 older adults followed for 6 to 8 years reported fewer deaths with it than in a control group, and in severe COVID-19 its developers report lower hospital mortality when it was added to basic therapy; neither study is described as randomized or blinded, and almost all of the work is by its developers. It is a different substance from thymulin and from thymosin alpha-1.
- VilonA dipeptide, Lys-Glu (KE), from Vladimir Khavinson's St. Petersburg bioregulator program and one of the active parts of the thymus extract Thymalin; Russian papers call it thymomimetic, a peptide that acts like the thymus on the immune system. In lymphocytes from old people grown in the lab it loosened tightly packed chromatin, which its developers read as switching silenced genes back on, and in old male rats it raised sexual function and lowered prolactin. In people with type 1 diabetes, small Russian studies with no placebo group report calmer blood clotting and, in most, less insulin needed. Almost all of the research is by its developers.
- Commonly reported
- ThymalinLittle to feel during a course; injection-site soreness is the usual complaint.
- VilonLittle to feel during a short course; it is often run beside Epitalon.
- Studied range
- ThymalinNo study indexed on PubMed states or tests a dose of Thymalin: the amounts people run are their own protocol, not a reference.
- VilonNo controlled study has set a dose of Vilon: the amounts people run are their own protocol, not a reference.
- How often
- ThymalinDaily
- VilonDaily
- Half-life
- ThymalinUnknown (never measured)
- VilonUnknown (never measured)
- Route
- ThymalinIM injection, SubQ injection
- VilonSubQ injection, Oral capsules
- Typical run
- ThymalinRun in short courses rather than continuously, like the other bioregulators: commonly 5–10 days, repeated months later. In the long Russian follow-up study, courses were given during the first two to three years only. No study has tested a course length.
- VilonRun in short courses rather than continuously, like the other bioregulators: community courses run about 5–10 days, a few times a year. No study has tested a course length.
- Evidence
- ThymalinEmerging: primarily preclinical / limited human data
- VilonEmerging: primarily preclinical / limited human data
- Common side effects
- ThymalinInjection-site pain or redness, firmness at the injection site
- VilonInjection-site discomfort, mild stomach upset (capsules)
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Thymalin
- Day 1–10 A short course, then a long gap
- Day 10–60 What the studies measured after a course
- Day 60–365 The long study in older adults
Vilon
- Day 1–10 A short pulse, not a daily habit
- Day 10–60 Where its human studies looked
Together or one or the other
Thymalin and vilon are a common stack: vilon lists thymalin among its common stacks.
Community · Vilon
Already inside Thymalin
Vilon is one of the active parts of Thymalin, so running both doubles up on the same dipeptide. No study has tested the pair.
Questions people ask
How long do thymalin and vilon last?
The half-life of thymalin is unknown (never measured). The half-life of vilon is unknown (never measured).
How often are thymalin and vilon taken?
Thymalin: daily. Routes: IM injection, subQ injection. Vilon: daily. Routes: SubQ injection, oral capsules.
How are thymalin and vilon dosed in research?
The library carries no reference dose for thymalin. No study indexed on PubMed states or tests a dose of Thymalin: the amounts people run are their own protocol, not a reference. The library carries no reference dose for vilon. No controlled study has set a dose of Vilon: the amounts people run are their own protocol, not a reference.
What are the common side effects of thymalin and vilon?
For thymalin, the library lists: injection-site pain or redness, firmness at the injection site. For vilon: injection-site discomfort, mild stomach upset (capsules).
Are thymalin and vilon taken together?
Thymalin and vilon are a common stack: vilon lists thymalin among its common stacks. Vilon is one of the active parts of Thymalin, so running both doubles up on the same dipeptide. No study has tested the pair.